A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)

Summary

A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Clinical Study ,the mean change from baseline in vertex target area hair count (TAHC) after treatment for 24 weeks.

Timeline

Start

2021-12-06

Primary completion

2023-03-07

Completion

2023-05-15

Publications

• Zhou C, Yang B, Zeng H, Xia R, Dang N, Yang Q, Li J, Zhang C, Zhang G, Wei A, Lai W, Yang S, Diao Q, Ding Y, Wu L, Liu L, Jia D, Zhu H, Zhang J. Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study. Chin Med J (Engl). 2026 Apr 5;139(7):1054-1061. doi: 10.1097/CM9.0000000000003495. Epub 2025 Mar 17.

Drugs

Indications